Option Care Health, Inc. · NASDAQ:OPCH

Option Care Health — Q4 2025 Earnings Presentation

16 slides from Option Care Health's earnings presentation, Feb 24, 2026

  1. Slide 1: Extraordinary Care That Changes Lives

    Extraordinary Care That Changes Lives Option Care Health, Inc. February 2026 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 1

  2. Slide 2: Disclaimers

    Disclaimers Forward-Looking Statements This presentation may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “pla

  3. Slide 3: Our purpose and our mission

    Our purpose Provide extraordinary care that changes lives. Our mission Transform healthcare by providing innovative services that improve outcomes, reduce overall costs of care and deliver hope for patients and families. © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation | Feb

  4. Slide 4: Option Care Health is a Leading Independent Provider of Home and Alternate Site Infusion Services

    Option Care Health is a Leading Independent Provider of Home and Alternate Site Infusion Services National Scale with Local Responsiveness o Resilient full-service 315,000+ network that Patients Served in 2025 supports a broad set of clinical services 5,000+ across a variety of Multidisciplinary Cli

  5. Slide 5: On the Right Side of Healthcare: Meeting Needs to Capture Growing Demand at Scale

    On the Right Side of Healthcare Meeting Needs to Capture Growing Demand at Scale1 o U.S. Home Infusion industry projected to grow high single Home Infusion Landscape digit % annually, driven by therapy growth, cost pressures & patient preference including ‘aging in place’ trends Option Care Health o

  6. Slide 6: Secular and Industry Trends Driving Toward Lower-Cost Home and Alternate Site Care

    Secular and Industry Trends Driving Toward Lower- Cost Home and Alternate Site Care Policy & Shifting Patient Site-of-Care Pharmaceutical Technology & Reimbursement Demographics Shifts Innovation Data Evolution Landscape • Aging population • Higher-acuity • Expansion of • Greater use of • Ongoing an

  7. Slide 7: Durable and Resilient Portfolio

    Durable and Resilient Portfolio Therapies, Pharma Programs & Payer Partnerships 2.5 million+ 315,000+ Infusions administered in 2025 Patients Served in 2025 600+ Therapies served in 2025, including limited 92% distribution drugs and pharma programs Overall Patient Satisfaction 88% 2025 revenue from

  8. Slide 8: Diversified Revenue & Gross Profit Mix Drives Sustainable Growth

    Diversified Revenue & Gross Profit Mix Drives Sustainable Growth1 Revenue Mix Gross Profit Mix o Branded therapies represent ~50% of revenue but <20% of gross profit Biosimilar Generic o Gross profit composed Biosimilar primarily of multisource generic & biosimilar Generic therapies Branded o Expand

  9. Slide 9: Delivered Strong 2025 Results

    Delivered Strong 2025 Results FY ’25 Results + Growth vs. PY o Net Revenue $5.65B, +13% o Adj. Diluted EPS $1.72, +9% o Adj. EBITDA $471M, +6% o Cash Flow from Operations $258M o Strategic inventory purchases and higher working capital from business growth o Repurchased $307M of shares © 2026 OPTION

  10. Slide 10: Well Positioned for Growth and Value Creation in '26

    Well Positioned for Growth and Value Creation in ’26 ’26 Guidance Guidance Key Assumptions + Growth vs. PY1 o Net Revenue $5.8B to $6.0B, +4% o (400bps) revenue growth headwind driven by Stelara IRA2 and Stelara biosimilars o Adj. Diluted EPS $1.82 to $1.92, +9% conversion o Adj. EBITDA $480M to $50

  11. Slide 11: Strong Record of Revenue Growth & Operating Leverage

    Strong Record of Revenue Growth & Operating Leverage Revenue Adj. EBITDA + Margin +13% $5.65B $471M +16% CAGR CAGR $3.0B $222M 7.3% 8.3% 2020 2025 2020 2025 Demonstrated Ability to Execute and Deliver on Growth Commitments © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation | F

  12. Slide 12: Strategic Capital Deployment Balancing Growth & Return to Shareholders

    Strategic Capital Deployment Balancing Growth & Return to Shareholders Strategic Capital Deployment | ’21 –’25 ~$1.4B $180M Operating Cash Flow | ’21 – ’25 CapEx Strong and consistent cash generation profile $1.3B $303M >$600M 2.0x $808M Share deployed since ’21 M&A Liquidity1 Net Debt Leverage Rati

  13. Slide 13: Compelling Investment Proposition

    Compelling Investment Proposition Shifts Toward Cost- National Scale with Diversified, Resilient Effective Home & Local Responsiveness Portfolio of Therapies & Alternate Site Care Models Pharma Programs Longstanding Payer Track Record of Double- Proven, Experienced Partnerships with 96% Digit Growth

  14. Slide 14: Contact Us

    Contact Us Our Website investors@optioncarehealth.com optioncarehealth.com © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation | February 2026 14

  15. Slide 15: Reconciliation to Non-GAAP Measures

    Reconciliation to Non-GAAP Measures For historical reconciliations of non-GAAP financial measures, please see our SEC filings and other financial reports, which are available on our website at investors.optioncarehealth.com © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation |

  16. Slide 16: Reconciliation to Non-GAAP Measures

    Reconciliation to Non-GAAP Measures For historical reconciliations of non-GAAP financial measures, please see our SEC filings and other financial reports, which are available on our website at investors.optioncarehealth.com © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation |

Option Care Health — Q4 2025 Earnings Presentation on 6ix